Mr. McInerney has 25 years of experience in the investment and pharmaceutical industries and has been a member of the Board of Directors since 2008. He is also the Chairman of the Board’s Nomination and Governance Committee as well as a member of the Board’s Audit Committee. Mr. McInerney is currently a partner with Riverbank Capital Securities, an investment banking firm specializing in biotechnology and specialty pharmaceutical companies.
Related Articles on Ophthalmology:
Acuity Laser Eye and Vision Center’s Dr. Steven Vale: Eye Surgery Should Be Limited to Physicians
Study: Use Grade 2 Reading Level, DVDs for Cataract Surgery Informed Consent
Nanoparticles to Deliver Steroids to the Retina
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
